No Detail Found!

Resistomycin, a pentacyclic polyketide, inhibits the growth of triple negative breast cancer cells through induction of apoptosis and mitochondrial dysfunction

Author(s)
Ammara Riaz Department of Zoology, Government College University,Faisalabad,Pakistan
Azhar Rasul Department of Zoology, Government College University,Faisalabad,Pakistan
Ghulam Hussain Department of Physiology, Government College University,Faisalabad,Pakistan
Malik Saadullah Department of Pharmaceutical Chemistry, Government College University,Faisalabad,Pakistan
Bilal Rasool Department of Zoology, Government College University,Faisalabad,Pakistan
Iqra Sarfraz Department of Zoology, Government College University,Faisalabad,Pakistan
Muqaddas Masood The Key Laboratory of Molecular Epigenetics of MOE, Institute of Genetics and Cytology, Northeast Normal University (NENU),Changchun,China
Muhammad Asrar Department of Zoology, Government College University,Faisalabad,Pakistan
Farhat Jabeen Department of Zoology, Government College University,Faisalabad,Pakistan
Tayyaba Sultana Department of Zoology, Government College University,Faisalabad,Pakistan
Abstract
Triple negative breast cancer (TNBC) stands among the most fatal and aggressive malignancies of women all over the world. This study was based on the screening of natural compounds library to identify potentially active entities against TNBC, which has been reported to be resistant towards currently available chemotherapeutics. A library of 100 compounds was screened against TNBC and non-TNBC breast cancer cell lines. Compounds that exhibited cytotoxicity and inhibited 80% growth of cancer cells at the concentration of 10µg/ml were considered as hits. 4 out of 100 screened compounds exhibited anti-proliferative potential against breast cancer while 2 out of 4 showed significant anti-cancer potential only against TNBC. In this article, we report the anti-cancer potential of resistomycin, a pentacyclic polyketide metabolite, which is isolated from bacterial strain Streptomyces spp. Resistomycin inhibited the growth of TNBC cells (MDA-MB231) more efficiently than non-TNBC (MCF-7) cells. Further, the molecular mechanism lying behind the anticancer potential of resistomycin was found to be induction of apoptosis and mitochondrial dysfunction. Resistomycin has significant potential to dissipate MMP to induce apoptosis in TNBC cells. The results of this research provide evidence to support this bioactive natural entity as an anti-TNBC drug candidate in future.
Publication Details
Page(s) 1233-1238
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 33, Issue: SUP3, Year: 2020

Request the full text from PASTIC

Keywords
resistomycin, Anticancer, Natural compounds, Triple negative breast cancer, Anticancer, Anticancer
References
Bioorg .2006 .Cytotoxic Compounds from the Marine Actinobacterium Streptomyces corchorusii AUBN1/71. , 32(3) : 295-300.
Atanasov AG,Waltenberger B,Pferschy-Wenzig EM,Linder T,Wawrosch C,Uhrin P,Temml V,Wang L,Schwaiger S,Heiss EH,Rollinger JM,Schuster D,Breuss JM,Bochkov V,Mihovilovic MD,Kopp B,Bauer R,Dirsch VM,Stuppner H VM .2015 .Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol Adv., 33(8) : 1582-1614.
Chavez KJ,Garimella SV,Lipkowitz S SV .2010 .Triple negative breast cancer cell lines: One tool in the search for better treatment of triple negative breast cancer. Breast Dis, 32(1-2) : 35-48.
Choudhari AS,Mandave PC,Deshpande M,Ranjekar P,Prakash O .2019 .Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice. , 01614 : .
Cleator S,Heller W,Coombes RC .2007 .Triplenegative breast cancer: therapeutic options. Lancet Oncol, 8(3) : 235-244.
Di W,Khan M,Rasul A,Sun M,Sui Y,Zhong L,Yang L,Zhu Q,Feng L,Ma T .2014 .Isoalantolactone inhibits constitutive NF-kappaB activation and induces reactive oxygen species-mediated apoptosis in osteosarcoma U2OS cells through mitochondrial dysfunction. Oncol Rep, 32(4) : 1585-1593.
Gadi VK,Davidson NE .2017 .Practical Approach to Triple-Negative Breast Cancer. J. Oncol. Pract, 13(5) : 293-300.
Han J,Lim W,You D,Jeong Y,Kim S,Lee JE,Shin TH,Lee G,Park S G,J Oncol. G .2019 .Chemoresistance in the Human Triple-Negative Breast Cancer Cell Line MDA-MB-231 Induced by Doxorubicin Gradient Is Associated with Epigenetic Alterations in Histone Deacetylase. , 10 : .
Jakobi K and Hertweck C .2004 .A gene cluster encoding resistomycin biosynthesis in Streptomyces resistomycificus; exploring polyketide cyclization beyond linear and angucyclic patterns. J. Am. Chem. Soc., 126(8) : 2298-2299.
Jitariu AA,Cimpean AM,Ribatti D,Raica M .2017 .Triple negative breast cancer: The kiss of death. Oncotarget, 8(28) : 46652-46662.
Jones SE,Elliot MA .2017 .Streptomyces Exploration: Competition, Volatile Communication and New Bacterial Behaviours. , 25(7) : 522-531.
Khan M,Yi F,Rasul A,Li T,Wang N,Gao H,Gao R .2012 .Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction. IUBMB Life, 64(9) : 783-794.
Kim C,Gao R,Sei E,Brandt R,Hartman J,Hatschek T,Crosetto N,Foukakis T,Navin NE .2018 .Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing. Cell, 173(4) : 879-893.
Li W,Liu J,Jackson K,Shi R,Zhao Y .2014 .Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells. PLoS One, 9(4) : e94079.
Nadysev GY,Tikhomirov AS,Lin MH,Yang YT,Dezhenkova LG,Chen HY,Kaluzhny DN,Schols D,Shtil AA,Shchekotikhin AE,Chueh PJ .2018 .Aminomethylation of heliomycin: Preparation and anticancer characterization of the first series of semisynthetic derivatives. Eur. J. Med, 143 : 1553-1562.
Plati J,Bucur O,Khosravi-Far R .2011 .Apoptotic cell signaling in cancer progression and therapy. Integr Biol. (Camb), 3(4) : 279-296.
Portha H,Jankowski C,Cortet M,Desmoulins I,Martin E,Lorgis V,Arnould L,Coutant C .2016 .Nonmetastatic triple-negative breast cancer in 2016: Definitions and management. Gynecol Obstet Fertil, 44(9) : 492-504.
Rasul A,Khan M,Yu B,Ma T,Yang H .2011 .Xanthoxyletin, a coumarin induces S phase arrest and apoptosis in human gastric adenocarcinoma SGC-7901 cells. Asian Pac. J. Cancer Prev, 12(5) : 1219-1223.
Riaz A,Rasul A,Hussain G,Zubair M,Samiullah K,Sarfraz I,Masood M,Jabeen F,Sultana T,Sultana S T .2019 .Eriocalyxin B induces apoptosis in human triple negative breast cancer cells via inhibiting STAT3 activation and mitochondrial dysfunction. Pak J Pharm Sci., 32(6) : 2483-2848.
Roggo BE,Petersen F,Delmendo R,Jenny HB,Peter HH,Roesel J .1994 .-hydroxymethyl tetronic acid homologues and resistomycin: new inhibitors of HIV-1 protease. I. Fermentation, isolation and biological activity. J. Antibiot (Tokyo), 47(2) : 136-142.
Safarzadeh E,Baradaran B .2014 .Herbal medicine as inducers of apoptosis in cancer treatment. Adv. Pharm. Bull., 4(Suppl 1) : 421-427.
Vijayabharathi R,Bruheim P,Andreassen T,Raja DS,Devi PB,Sathyabama S,Priyadarisini VB .2011 .Assessment of resistomycin, as an anticancer compound isolated and characterized from Streptomyces aurantiacus AAA5. , 49(6) : 920-926.
Xu X,Lai Y,Hua ZC Y .2019 .Apoptosis and apoptotic body: Disease message and therapeutic target potentials. Biosci Rep, 39(1) : 1-17.
Zhang YL,Li S,Jiang DH,Kong LC,Zhang PH,Xu JD .2013 .Antifungal activities of metabolites produced by a termite-associated Streptomyces canus BYB02. J. Agric. Food Chem, 61(7) : 1521-1524.
Zupko I,Jaeger W,Topcu Z,Wu CC .2015 .Anticancer properties of natural products. Biomed. Res. Int., 10 : .
0

Citations

0

Downloads

13

Views